Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 040784
Company: XGEN PHARMS

Products on ANDA 040784

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	AP	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 040784

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/10/2008	ORIG-1	Approval				Label is not available on this site.

Therapeutic Equivalents for ANDA 040784

ACETAZOLAMIDE SODIUM

INJECTABLE;INJECTION; EQ 500MG BASE/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	202693	AVET LIFESCIENCES
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	040089	HIKMA
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	200880	MYLAN ASI
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	040784	XGEN PHARMS
ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE;INJECTION	Prescription	No	AP	206533	ZYDUS PHARMS